Clinical Trial Update: Study of Gam-COVID-Vac in Adolescents [Phase 2, Phase 3]

View source ↗

Summary

A trial update for Gam-COVID-Vac in adolescents across Phase 2 and Phase 3 is currently listed with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vaccine-preventable Disease

Drugs mentioned

• Gam-COVID-Vac (unspecified)

Snippet

Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | Conditions: Covid19, Vaccine Preventable Disease | Phase 2, Phase 3 | Status: UNKNOWN